ACLF合并SBP患者发生AKI的危险因素分析

肝脏 ›› 2018, Vol. 23 ›› Issue (10): 860-863.

ACLF合并SBP患者发生AKI的危险因素分析

苏海滨, 刘晓燕, 陈婧, 李晨, 童晶晶, 徐祥, 关崇丹, 严立龙, 彭宇辉, 宁鹏, 李会, 胡瑾华

100039 北京解放军第三〇二医院肝衰竭诊疗与研究中心

收稿日期:2018-05-10 出版日期:2018-10-31 发布日期:2020-05-21
通讯作者: 胡瑾华,Email:13910020608@163.com

Analysis of risk factors for acute kidney injury in patients with acute on chronic liver failure complicated with spontaneous bacterial peritonitis

SU Hai-bin, LIU Xiao-yan, CHEN Jin, LI Chen, TONG Jin-jin, XU Xiang, GUAN Chong-dan, YAN Li-long, PENG Yu-hui, NING Peng, LI Hui, HU Jin-hua.

Liver failure treatment and research center, 302 hospital of PLA, Beijing 100039, China

Received:2018-05-10 Online:2018-10-31 Published:2020-05-21
Contact: HU Jin-hua,Email:13910020608@163.com

摘要/Abstract

摘要： 目的探讨慢加急性肝衰竭(ACLF)合并自发性细菌性腹膜炎(SBP)患者发生急性肾损伤(AKI)的危险因素。方法回顾性分析ACLF合并SBP患者AKI的发生率,对患者的一般情况、ACLF病因、实验室指标、有无合并其他部位感染以及初始抗感染治疗是否有效进行单因素及多因素分析。结果 370例ACLF合并SBP患者中,AKI的发生率为41.4%(153/370)。单因素分析发现,与未发生AKI的患者相比,发生AKI患者年龄、血WBC计数、总胆红素(TBil)、国际标准化比值(INR)以及C反应蛋白(CRP)均明显增高,分别为(51.5±41.6岁)比(48±11.1岁);(12.4±7.3)×10⁹/L比(8.8±5.3)×10⁹/L;(375.4±136.9) μmol/L比(347.8±121.2) μmol/L;(2.3±0.9)比(2.0±0.6);(37.1±32.8) μg/L比(23.0±19.2) μg/L,(均P<0.05),而平均动脉压(MAP)、血清白蛋白(Alb)、血清Na⁺水平以及初始抗感染治疗的有效率均明显降低(86.9±13.8) mmHg比(90.6±9.9) mmHg;(26.6±5.6) g/L比(28.7±8.3) g/L;(130.3±5.4) μmol/L比(133.5±4.5) μmol/L;57.0%比75.7%,(均P<0.05)。Logistic多因素分析发现,患者的年龄、WBC计数、血清Na⁺、CRP水平以及初始抗感染治疗是否有效是影响ACLF合并SBP患者发生AKI的重要因素。发生AKI的患者治疗无效率显著高于未发生者(60.1%比39.2%,P<0.05)。结论 ACLF合并SBP患者易发生AKI。患者年龄较大、WBC计数、CRP水平升高、血清Na⁺降低以及早期抗感染无效是发生AKI的高危因素。

关键词: 慢加急性肝衰竭, 自发性细菌性腹膜炎, 急性肾损伤

Abstract: Objective To study the risk factors for acute kidney injury (AKI) in patients with acute on chronic liver failure (ACLF) complicated with spontaneous bacterial peritonitis (SBP). OMethods The incidence of AKI in ACLF patients complicated with SBP was retrospectively analyzed. Basic information, etiology of ACLF, laboratory indexes, co-infection and the efficacy of early anti-infection therapy were analyzed using univariate and multivariate analysis. Results The incidence of AKI was 41.4% (153/370) in ACLF patients complicated with SBP. It was observed that age, white blood cell (WBC) count, total bilirubin level, international normalized ratio and C reactive protein (CRP) level were higher in patients with AKI than those in patients without, respectively [(51.5±41.6 years old vs. 48±11.1 years old, (12.4±7.3)×10⁹/L vs. (8.8±5.3)×10⁹/L, 375.4±136.9 μmol/L vs. 347.8±121.2 μmol/L, 2.3±0.9 vs. 2.0±0.6, 37.1±32.8 ug/L vs. 23.0±19.2 ug/L, all P<0.05]. However, levels of mean arterial pressure, albumin, serum Na⁺ and the response rate of initial anti-infection therapy were lower in patients with AKI than those in patients without, respectively (86.9±13.8 mmHg vs. 90.6±9.9 mmHg, 26.6±5.6 g/L vs. 28.7±8.3 g/L, 130.3±5.4 μmol/L vs. 133.5±4.5 μmol/L, 57.0% vs. 75.7%, P<0.05). It is revealed that age, WBC count, serum Na⁺ level, CRP level and the efficacy of early anti-infection therapy were associated with the development of AKI in ACLF patients with SBP. Moreover, treatment failure was more often in patients with AKI (60.1% vs. 39.2%, P<0.05).Conclusion ACLF patients with SBP are predisposed to AKI. The risk factors include old age, increased WBC count, high CRP level, low serum Na⁺ level and ineffective initial anti-infection therapy.

Key words: Acute on chronic liver failure, Spontaneous bacterial peritonitis, Acute kidney injury
,

苏海滨, 刘晓燕, 陈婧, 李晨, 童晶晶, 徐祥, 关崇丹, 严立龙, 彭宇辉, 宁鹏, 李会, 胡瑾华. ACLF合并SBP患者发生AKI的危险因素分析[J]. 肝脏, 2018, 23(10): 860-863.

SU Hai-bin, LIU Xiao-yan, CHEN Jin, LI Chen, TONG Jin-jin, XU Xiang, GUAN Chong-dan, YAN Li-long, PENG Yu-hui, NING Peng, LI Hui, HU Jin-hua.. Analysis of risk factors for acute kidney injury in patients with acute on chronic liver failure complicated with spontaneous bacterial peritonitis[J]. Chinese Hepatolgy, 2018, 23(10): 860-863.

参考文献

[1] Cheong HS, Kang CI, Lee JA, et al. Clinical significance and outcome of nosocomial acquisition of spontaneous bacterial peritonitis in patients with liver cirrhosis. Clin Infect Dis, 2009, 48: 1230-1236.
[2] Arroyo V, Jimenez W. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem. J Hepatol, 2000, 32(1 Suppl):s157-170.
[3] Cai J, Zhang M, Han T, et al. Characteristics of infection and its impact on short-term outcome in patients with acute-on-chronic liver failure. Medicine, 2017, 96: 1-9.
[4] Tandon P, Garcia-Tsao G. Renal dysfunction is the most important independent predictor of mortality in cirrhotic patients with spontaneous bacterial peritonitis. Clin Gastroenterol Hepatol, 2011, 9: 260-265.
[5] 中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2012). 中华肝脏病杂志, 2013, 21:177-183.
[6] 中华医学会肝病学分会. 肝硬化腹水及相关并发症的诊疗指南. 临床肝胆病杂志, 2017, 33:1847-1863.
[7] Angeli P, Ginès P, Wong F, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites. J Hepatol, 2015, 62: 968-974.
[8] Maiwall R, Sarin SK, Moreau R, et al. Acute kidney injury in acute on chronic liver failure. Hepatol Int, 2016, 10: 245-257.
[9] Zang H, Liu F, Liu H, et al. Incidence, risk factors and outcomes of acute kidney injury (AKI) in patients with acute-on-chronic liver failure (ACLF) of underlying cirrhosis. Hepatol Int, 2016, 10: 807-818.
[10] Angeli P, Tonon M, Pilutti C, et al. Sepsis-induced acute kidney injury in patients with cirrhosis. Hepatol Int, 2016, 10: 115-123.
[11] Shi X, Zhu P, Yan G, et al. Clinical characteristics and long-term outcome of acute kidney injury in patients with HBV-related acute-on-chronic liver failure. J Viral Hepat, 2016, 1-10.
[12] Cervoni JP, Thévenot T, Weil D, et al. C-reactive protein predicts short-term mortality in patients with cirrhosis. J Hepatol, 2012, 56: 1299-1304.
[13] Biggins SW, Kim WR, Terrault NA, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology, 2006, 130: 1652-1660.
[14] Piano S, Fasolato S, Salinas F, et al. The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: results of a randomized, controlled clinical trial. Hepatology, 2016, 63: 1299-1309.

[1]	陈艳, 林瑞, 陈竹, 王丽. 2012至2018年某院肝硬化并自发性细菌性腹膜炎的病原学及耐药性分析[J]. 肝脏, 2020, 25(2): 166-168.
[2]	贾瑾堂, 施文娟, 王兆勋, 田鹏飞. 乙型肝炎慢加急性肝衰竭患者血清γ干扰素水平变化的意义[J]. 肝脏, 2020, 25(1): 61-62.
[3]	袁宏香, 张秋云, 娄金丽, 于艳华, 赵艳. 慢加急性肝衰竭血小板减少患者血栓弹力图及常规凝血指标的变化[J]. 肝脏, 2020, 25(1): 20-23.
[4]	诸海军, 万健, 孙莲娜, 孙杰, 陈嵩. WBC、IL-6及NLR值对慢加急性肝衰竭患者的早期预警价值[J]. 肝脏, 2019, 24(9): 1076-1078.
[5]	刘亚迪, 孙双双, 徐浩, 李成忠. HBV相关慢加急性肝衰竭患者感染特点及危险因素分析[J]. 肝脏, 2019, 24(9): 1015-1019.
[6]	张志侨, 叶一农, 何纲, 王鹏, 李静, 吴兴柳. 乙型肝炎相关慢加急性肝衰竭患者急性肾损伤的影响因素和高危人群分析[J]. 肝脏, 2019, 24(9): 997-1001.
[7]	徐强, 马燕, 郭峰, 王晓波, 王晓忠. 肝硬化相关急性肾损伤30天内死亡的相关因素分析[J]. 肝脏, 2019, 24(8): 857-860.
[8]	钟慧筠, 殷思纯. HBV相关慢加急性肝衰竭器官衰竭危险因素及短期预后分析[J]. 肝脏, 2019, 24(6): 658-661.
[9]	郄永强, 周会杰. 血清IL-23对慢性乙型肝炎肝功能衰竭患者生存状况的影响[J]. 肝脏, 2019, 24(3): 274-276.
[10]	关菁, 徐玉敏, 冼永超, 黄成军, 赖荣陶, 王晓琳, 谢敬东, 蔡伟, 谢青. 外周血中性粒细胞与淋巴细胞数的比值预测慢加急性肝衰竭疾病进展和临床转归的研究[J]. 肝脏, 2019, 24(2): 130-132.
[11]	谢玲, 程丰, 孙文锦, 龚国富. 血清同型半胱氨酸联合降钙素原检测对HBV相关慢加急性肝衰竭患者短期预后的临床价值[J]. 肝脏, 2019, 24(12): 1402-1405.
[12]	王伟. 肝硬化并发急性肾损伤患者门静脉主干内径特征观察[J]. 肝脏, 2019, 24(11): 1290-1292.
[13]	王兆勋, 周渐, 施文娟, 张妍, 万红. 98例HBV相关慢加急性肝衰竭患者的临床特征与分析[J]. 肝脏, 2019, 24(10): 1176-1177.
[14]	郭世民, 魏巍, 张自然, 李婧, 赵和平. 血清M30及M65水平用于HBV相关慢加急性肝衰竭患者预后的临床价值[J]. 肝脏, 2018, 23(7): 607-610.
[15]	尹伟, 李成忠, 邹多武. 肝硬化急性肾损伤新标准(ICA2015)下治疗应答和预后的回顾性分析及影响因素研究[J]. 肝脏, 2018, 23(3): 201-205.